Julie Rubinstein $ADPT SEC Form 4 Insider Trading

Julie Rubinstein has filed a total of 10 insider trades in $ADPT since 2021. Their most recent trade was a sale of 30,941 shares, made on Mar 04, 2026. Their largest trade was a sale of 40,044 shares, made on Mar 05, 2025. We estimate that they now own 588,249 shares of $ADPT, worth an estimated $10.0 million.

Insider Trading at $ADPT

There have been a total of 199 insider trades reported at $ADPT since 2021, with 0 shares purchased and 4.7 million shares sold. The most active insider traders in $ADPT stock have been Harlan S Robins, Chad M Robins, and R Mark Adams. The most recent trade was a sale of 48,044 shares reported by MICHELLE RENEE GRIFFIN (None), made on Mar 03, 2026.

$ADPT Executives and Stock Owners with Insider Trades

• Harlan S Robins, Chief Scientific Officer

• Chad M Robins, CEO and Chairman

• R Mark Adams, Chief Operating Officer

• Chad M Cohen, Chief Financial Officer

• Stacy L Taylor, SVP and General Counsel

• Francis Lo, Chief People Officer

• Kyle Piskel, Chief Financial Officer

• Sharon Benzeno, Chief Commercial Ofc Imm Med

• Nitin Sood, Chief Commercial Officer, MRD

• Kyle Piskel, Principal Accounting Officer

• Julie Rubinstein, President and COO

• Tycho Peterson, Chief Financial Officer

• Julie Rubinstein, President

• Jyoti Palaniappan, SVP, Diagnostics, T-Detect

• Susan Bobulsky, Chief Commercial Officer, MRD

• Lance Baldo, Chief Medical Officer

• Sharon Benzeno, Chief Business Development Off

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.